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Since the acceptance of surgery as a treatment strategy for
ruptured cerebral aneurysms in the 1960s there has been
constant improvement in patient outcomes. Initially this was
because of improvements in operative technique such as use of
the operating microscope and new clip designs for aneurysm
occlusion. Later improvements were due to an evolving
understanding of the pathology of subarachnoid haemorrhage
(SAH) and intensive care advances. In the early 1990s further
progress was made with the development of the Gugliemi
detachable coil (GDC). This allowed for the occlusion of
cerebral aneurysms without the need for a craniotomy and
brain retraction. It now became possible to treat an aneurysm
endovascularly by passing a microcatheter from the groin into
the aneurysm dome through the arterial system. Once the
catheter was in place platinum GDC coils could then be
introduced through the catheter into the aneurysm until it was
completely occluded. Thrombosis and later healing by
endothelialisation allowed for exclusion of the aneurysm from
the arterial system (Fig. 1). The recent International
Subarachnoid Aneurysm Trial (ISAT) which randomised
patients with ruptured aneurysms to either surgical or
endovascular treatment, showed reduced death and serious
morbidity in the endovascular group, validating this therapy.1
In 2001, through a process of subspecialisation, we began
endovascular treatment and microsurgical treatment of
aneurysms at Groote Schuur Hospital and the University of
Cape Town academic complex. To date we have treated over 90
aneurysm patients endovascularly and in doing this have built
up a neurovascular unit that serves to treat patients, teach
students and train specialists. It was our impression that in
developing this expertise we had improved our overall care of
patients with neurovascular disease. To assess this we
examined outcomes of patients treated for cerebral aneurysms
before and after our use of endovascular techniques in a
retrospective cohort study.
Methods
Over a period of 3 years and 8 months, spanning October 1994
to July 1998, 245 cerebral aneurysm patients were treated in our
unit. Demographic, clinical, complication and outcome data in
the form of a Glasgow Outcome Score (GOS) were available for
this group from a previously unpublished study. This
information was obtained initially by reviewing hospital
records. During this period only surgery was used as a
treatment strategy. Over a 19-month period from July 2002 to
February 2004 similar information was collected for 82 patients
treated either surgically or by endovascular occlusion, or with
a combination of both. This information was obtained from the
patients’ hospital folders.
In order to standardise evaluation, patients with multiple
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treatment option for each patient and believe this has
contributed to our improved results. 
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aneurysms who received treatments at different times were
treated as new admissions. After treatment of a ruptured
aneurysm patients with another aneurysm were reflected in the
unbled aneurysm group as new patients. However, if multiple
aneurysms were treated during the same procedure this was
reflected as 1 admission. 
During the period 1994 - 1998 our standard approach to
cerebral aneurysms was a pterional craniotomy and
microsurgical clipping of the aneurysm. Because of resource
limitation we had a policy of only admitting patients with good
neurological status (WFNS score of I or II); however if poor-grade
patients were admitted to our service they were also treated
surgically if their condition improved. As far as possible
patients were managed in high care or intensive care.
Hypervolaemia was the primary strategy for treating SAH-
related vasospasm. From 2001 and during the treatment period
of the second cohort our admission criteria remained the same;
however we introduced some changes to aneurysm
management. The most significant change was the capacity to
treat aneurysms endovascularly. Over 50% of aneurysms in the
second cohort were treated endovascularly. We also started to
use angioplasty for patients who developed vasospasm and
who were unresponsive to hypervolaemia. As far as possible
patients were treated in a high-care setting, but endovascularly
treated patients were often treated under local anaesthetic and
recovered in a normal ward. Changes were also made with
regard to our microsurgical approaches. In addition to the
pterional approach many patients had their aneurysms clipped
through a minimally invasive ‘key hole’ supraorbital
craniotomy.  
Analysis
Parametric variables were analysed using descriptive statistics,
and cohorts were compared using an unpaired t-test. Non-
parametric variables were analysed using either a chi-squared
test or Fisher’s exact test. The timing of outcome assessment
was at the point of patient discharge. This is not ideal when
examining for subtle neurological differences between groups
but is acceptable when using death and major disability as
outcome.  Mortality tends to be related to aneurysm rupture or
treatment complications and occurs early rather than after
discharge from hospital. Few patients who have a major
disability are likely to improve to the point where they are
independent so time should not alter outcome assessment
significantly. Outcomes were compared by stratifying cohorts
into two groups, namely favourable and unfavourable
outcome. Favourable outcome included patients who were
normal or who had only minor disability, i.e. GOS 4 and 5.
Unfavourable results included patients with major disability,
and those who were vegetative or dead. These were GOS 1 - 3
patients. Results were then analysed using a Fisher’s exact test
looking for a significant difference between them. Statistical
analysis was performed using Graphpad software.
Results
Over a 44-month period (October 1994 - July 1998) 245 patients
with cerebral aneurysms were treated; an average of 66.8
patients per year. During the later collection period of 19
months, 83 patients with aneurysms were treated, giving an
average of 52.4 patients per year. Patients in both groups were
comparable with regard to age, with the average age in the first
cohort being 47.8 years and in the second 46.6 years. The
percentage of female patients in each group was also similar,
with 67% in the first group and 70% in the second group. The
most important determinant of outcome, the admission World
Federation of Neurological Surgeons (WFNS) score, also
showed good correlation between cohorts, with no significant
Fig. 1.  Cerebral angiogram showing a posterior communicating
region aneurysm before and after endovascular coiling. 
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differences between groups for unruptured, poor or good-
grade patients (Table I).
In the early group 75% of patients had a craniotomy; the
remaining 25% had no treatment as they died before surgery
could be performed. In the later cohort 35% had surgery and
55% were treated endovascularly, with the balance undergoing
a combination of the two.  Analysis of outcomes between the
two groups showed a significant difference, with reduced
morbidity and mortality in the later cohort. In the early cohort
the management mortality and major morbidity across all
patients was 24% as opposed to 8% in the later cohort
(p = 0.0015, Fisher’s exact test). Cause of death in the early
group was primarily re-bleeding, with 34 of 51 patients dying
before surgery was performed. Ischaemic complications from
vasospasm were also high in this group, with 14 patients dying
from this complication. In the later series there were only 4
deaths. One was related to re-bleeding and 1 to vasospasm. As
re-bleeding is directly related to a delay in securing a ruptured
aneurysm, time to treatment was reviewed in each cohort. In
the early group the average time to surgery was 7.5 days (95%
confidence interval (CI): 6.4 - 8.6) and in the later group the
time to treatment using either surgical or endovascular
methods was 9.3 days (95% CI: 6.9 - 11.7). This difference was
not statistically different; however there was a difference
between endovascular and surgical timing of treatment in the
second group. On average endovascular patients were treated
on day 4.4 and surgical patients on day 17.9. When the time to
treatment was analysed between the first group and endo-
vascular patients in the second group the difference was
significant (p = 0.008, t-test) suggesting that early endovascular
treatment may have protected against re-bleeding (Table I).
Discussion
Management-related adverse outcome for all patients admitted
with aneurysmal SAH is reported in the literature to range
from 27% to 44%.2-5 This is substantially higher than the 8 - 24%
reported in our selected series. Because of resource limitation
we have had a policy of only admitting patients who have a
high chance of making a functional recovery. Most of our
patients have good WFNS scores at the time of admission,
which results in a skew to improved outcomes. Despite this we
were still able to improve further on our patient outcomes by
introducing new treatment techniques. An absolute reduction
of 16% in mortality and major morbidity was achieved
primarily through starting an endovascular programme at our
hospital. This effect has been noted by other researchers.6,7
Johnston7 examined the impact of endovascular services at
university hospitals in North America. Institutions offering
endovascular treatment showed a 9% reduction in inpatient
hospital mortality per 10% of patients treated endovascularly
for ruptured cerebral aneurysms.7 In another study,  Berman 
et al.6 showed that both endovascular treatment and procedural
volume were independently associated with better outcomes in
aneurysm treatment.
Whether the reduced mortality and morbidity in this and
other studies is due solely to endovascular treatment is unclear.
The ISAT trial,1 which compared outcomes in patients
randomised to surgery versus endovascular treatment, showed
an absolute risk reduction of dependence or death of 6.9% in
the endovascular group. This latter study has been largely
responsible for the increasing numbers of patients referred for
endovascular treatment since 2002. We have demonstrated that
in our environment we were able to treat patients sooner using
endovascular management. Not only are waiting times
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Table I. Summary of results
Surgical and 
Surgical treatment endovascular treatment
October 1994 - July 1998 July 2002- February 2004 p-value
Number of patients 245 83
Method of treatment (%)
Surgical 183 (75) 29 (35)
Endovascular 46 (55)
Patient age (yrs) 47.8 46.6 0.45
95% CI 46.3 - 49.3 43.6 - 49.6
Male/female ratio
Female (%) 67 70 0.78
Male (%) 33 30
Clinical grade (%)
Unbled 41 (17) 9 (11) 0.292
Good grade 154 (63) 60 (72)
Poor grade 50 (20) 14 (17)
Outcome (%)
Unfavourable 59 (24) 7 (8) 0.001
Favourable 186 (76) 76 (92)
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shortened because we can proceed without anaesthesia or an
operating list, but the risk of aggravating vasospasm is less of a
concern with endovascular approaches than it is with surgery.8
In so doing we have reduced re-bleeding and vasospasm as
causes of death. However, other possibilities exist for improved
patient outcome. We believe that in having two treatment
strategies we are able to choose the safest procedure for each
individual, taking into account variables such as age, co-
morbidity and aneurysm anatomy. This approach undoubtedly
also improves surgical outcomes because high-risk surgical
candidates, such as patients with basilar artery or paraclinoid
aneurysms, are often low-risk endovascular cases.9
Of course costs of endovascular treatment are cause for
concern. The platinum coils and microcatheters used are
expensive compared with the consumables used for surgery.
However if factors such as admission time, anaesthetic costs,
theatre time and rehabilitation expenses are taken into account,
endovascular treatment is less expensive overall.10 This is
especially true of unruptured aneurysms where cost reduction
is dramatic. In a public health care system where budgets are
limited and focused on containing consumable costs it is hard
to justify expensive therapies. We have been fortunate to
receive support from our hospital for starting and continuing
our programme. Because of this we have been able to improve
patient outcomes, and benefits have extended to other patients
as well. Our work is performed in an angiogram suite and
procedures are often done under local anaesthetic; because of
this more operating time is available for other patients.
Endovascularly treated patients also spend less time in
intensive care units, again freeing up a constrained resource.
We believe that these and other advantages easily compensate
for the consumable costs incurred.
Endovascular approaches to cerebrovascular pathology offer
the exciting possibility of further reducing the burden of
disease. Advances are ongoing and it is important that we
build up and maintain this growing field in South Africa.  
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